Curcumin for maintenance therapy in ulcerative colitis - Reply

被引:0
|
作者
Koide, Yukio [1 ]
机构
[1] Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka 43131, Japan
关键词
D O I
10.1016/j.cgh.2007.03.003
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:642 / 642
页数:1
相关论文
共 50 条
  • [1] Curcumin for maintenance of remission in ulcerative colitis
    Kumar, Sushil
    Ahuja, Vineet
    Sankar, Mari Jeeva
    Kumar, Atul
    Moss, Alan C.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (10):
  • [2] Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis REPLY
    Sands, Bruce E.
    Marano, Colleen
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (01): : 91 - 91
  • [3] Maintenance therapy options for ulcerative colitis
    Chaparro, Maria
    Gisbert, Javier P.
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (10) : 1339 - 1349
  • [4] CORTICOSTEROID THERAPY IN ULCERATIVE COLITIS - REPLY
    PRESCOTT, RJ
    MCMANUS, JPA
    NEW ENGLAND JOURNAL OF MEDICINE, 1970, 283 (10): : 540 - &
  • [5] Maintenance therapy for ulcerative colitis has no impact on changes in the extent of ulcerative colitis
    Eleftheriadis, N.
    Lambrecht, G.
    D'Haens, G.
    Baert, F.
    Cabooter, M.
    Louis, E.
    Van Assche, G.
    Schuumans, P.
    Caenepeel, P.
    Van Outryve, M.
    Lammens, P.
    Van Gossum, A.
    De Vosa, M.
    JOURNAL OF CROHNS & COLITIS, 2007, 1 (01): : 21 - 27
  • [6] Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
    Dai, Cong
    Jiang, Min
    Sun, Ming-Jun
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (05): : 496 - 496
  • [7] Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
    Sandborn, William J.
    Su, Chinyu
    Sands, Bruce E.
    D'Haens, Geert R.
    Vermeire, Severine
    Schreiber, Stefan
    Danese, Silvio
    Feagan, Brian G.
    Reinisch, Walter
    Niezychowski, Wojciech
    Friedman, Gary
    Lawendy, Nervin
    Yu, Dahong
    Woodworth, Deborah
    Mukherjee, Arnab
    Zhang, Haiying
    Healey, Paul
    Panes, Julian
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (18): : 1723 - 1736
  • [8] Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis
    Sands, B. E.
    Sandborn, W. J.
    Panaccione, R.
    O'Brien, C. D.
    Zhang, H.
    Johanns, J.
    Adedokun, O. J.
    Li, K.
    Peyrin-Biroulet, L.
    Van Assche, G.
    Danese, S.
    Targan, S.
    Abreu, M. T.
    Hisamatsu, T.
    Szapary, P.
    Marano, C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (13): : 1201 - 1214
  • [9] Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis
    D'Haens, Geert
    Dubinsky, Marla
    Kobayashi, Taku
    Irving, Peter M.
    Howaldt, Stefanie
    Pokrotnieks, Juris
    Krueger, Kathryn
    Laskowski, Janelle
    Li, Xingyuan
    Lissoos, Trevor
    Milata, Joe
    Morris, Nathan
    Arora, Vipin
    Milch, Catherine
    Sandborn, William
    Sands, Bruce E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (26): : 2444 - 2455
  • [10] Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
    Feagan, Brian G.
    Rutgeerts, Paul
    Sands, Bruce E.
    Hanauer, Stephen
    Colombel, Jean-Frederic
    Sandborn, William J.
    Van Assche, Gert
    Axler, Jeffrey
    Kim, Hyo-Jong
    Danese, Silvio
    Fox, Irving
    Milch, Catherine
    Sankoh, Serap
    Wyant, Tim
    Xu, Jing
    Parikh, Asit
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (08): : 699 - 710